WMAR Baltimore, MD on MSN
Cancer survivor's recovery through hyperbaric oxygen therapy
Marc Hickel thought his battle with prostate cancer was over after surgery and radiation treatment. But five years later, ...
Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk ...
BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback